3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
NET
1
Endocrine
1
Conditions
Neuroendocrine Tumors
4
Serotonin Syndrome
2
Carcinoid Tumor
2
Prostatic Neoplasms
1
Pituitary Neoplasms
1
Peritoneal Neoplasms
1
Pancreatic Neoplasms
1
Neuroendocrine Tumors in Lung
1
Intestinal Obstruction
1
Growth Hormone-Secreting Pituitary Adenoma
1
Gastro-enteropancreatic neuroendocrine tumor
1
Flushing
1
Endocrine Tumors
1
Diarrhea
1
Carcinoma
1
Carcinoid Heart Disease
1
Adenoma, Islet Cell
1
Acromegaly
1
Interventions
Octreotide
3
maltodextrin
1
lanreotide
1
Sulfasalazine
1
Radiation
1
Probiotics
1
Loperamide
1
Levofloxacin
1
Irinotecan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Diarrhea
×
lanreotide
×
Clear all
NCT00774930
2022-10-14
ELECT
Ipsen
Phase 3
Completed
115 enrolled
17 charts